drugset / Trial / NCT07323732

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

NCT07323732

Phase 2 Recruiting 25 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people with non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD).

Timeline

Start
2026-01-06
Primary completion
2029-01-06
Completion
2029-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Genistein Other / unclassified